A Director at Tandem Diabetes Care is Exercising Options

Yesterday it was reported that a Director at Tandem Diabetes Care (TNDM – Research Report), Dick Allen, exercised options to sell 2,599 TNDM shares at $73.73 a share, for a total transaction More »

Wedbush Sticks to Its Buy Rating for Verona Pharma (VRNA)

Wedbush analyst Liana Moussatos reiterated a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $60.00. The company’s shares closed last Monday at $5.85. According More »